ADMS - Adamas Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/4/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
72.09M81.38M105.99M142.49M170.71M
Enterprise Value 3
93.92M-51.23M90.17M105.74M109.62M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
1.241.462.022.903.92
Price/Book (mrq)
N/AN/A5.363.342.69
Enterprise Value/Revenue 3
1.63-3.545.527.598.64
Enterprise Value/EBITDA 6
-1.234.01-4.70-4.51-5.28

Trading Information

Stock Price History

Beta (5Y Monthly) 1.80
52-Week Change 3-55.93%
S&P500 52-Week Change 36.72%
52 Week High 37.7800
52 Week Low 31.9000
50-Day Moving Average 32.7574
200-Day Moving Average 33.6827

Share Statistics

Avg Vol (3 month) 3470.85k
Avg Vol (10 day) 3381.96k
Shares Outstanding 528.16M
Float 20.33M
% Held by Insiders 12.81%
% Held by Institutions 179.07%
Shares Short (Jun 14, 2020) 41.27M
Short Ratio (Jun 14, 2020) 42.34
Short % of Float (Jun 14, 2020) 45.44%
Short % of Shares Outstanding (Jun 14, 2020) 44.52%
Shares Short (prior month May 14, 2020) 41.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin -160.44%
Operating Margin (ttm)-133.66%

Management Effectiveness

Return on Assets (ttm)-26.12%
Return on Equity (ttm)-383.56%

Income Statement

Revenue (ttm)57.45M
Revenue Per Share (ttm)2.07
Quarterly Revenue Growth (yoy)24.10%
Gross Profit (ttm)52.17M
EBITDA -75.71M
Net Income Avi to Common (ttm)-92.18M
Diluted EPS (ttm)-3.3130
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)115.28M
Total Cash Per Share (mrq)4.09
Total Debt (mrq)137.12M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.61
Book Value Per Share (mrq)-0.56

Cash Flow Statement

Operating Cash Flow (ttm)-77.17M
Levered Free Cash Flow (ttm)-50.97M